Cholesterol biosynthesis modulation regulates dengue viral replication (Q39856050)

15 September 2017

title

Cholesterol biosynthesis modulation regulates dengue viral replication (English)

1 reference

15 September 2017

0 references

Christopher Rothwell

1

1 reference

15 September 2017

Aude Lebreton

2

1 reference

15 September 2017

Chuan Young Ng

3

1 reference

15 September 2017

Joanne Y H Lim

4

1 reference

15 September 2017

Wei Liu

5

1 reference

15 September 2017

Subhash Vasudevan

6

1 reference

15 September 2017

Mark Labow

7

1 reference

15 September 2017

Feng Gu

8

1 reference

15 September 2017

L Alex Gaither

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

5 May 2009

1 reference

15 September 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

15 September 2017

volume

389

1 reference

15 September 2017

issue

1-2

1 reference

15 September 2017

page(s)

8-19

1 reference

SREBP in signal transduction: cholesterol metabolism and beyond

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Importance of mevalonate-derived products in the control of HMG-CoA reductase activity and growth of human lung adenocarcinoma cell line A549.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Optimization procedure for small interfering RNA transfection in a 384-well format

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Statins inhibit HIV-1 infection by down-regulating Rho activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Protein sensors for membrane sterols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Immunopathological mechanisms in dengue and dengue hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Regulation of isoprenoid/cholesterol biosynthesis in cells from mevalonate kinase-deficient patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Different anti-HCV profiles of statins and their potential for combination therapy with interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Partial deletion of membrane-bound domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase eliminates sterol-enhanced degradation and prevents formation of crystalloid endoplasmic reticulum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Identification of active site residues in mevalonate diphosphate decarboxylase: implications for a family of phosphotransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

The effects of statin therapy on plasma markers of inflammation in patients without vascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Cholesterol Effectively Blocks Entry of Flavivirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Molecular biology of flaviviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Cholesterol manipulation by West Nile virus perturbs the cellular immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

West Nile Virus Entry Requires Cholesterol-Rich Membrane Microdomains and Is Independent of v 3 Integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Structural proteomics of dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Monoclonal antibodies raised to the dengue-2 virus (Cuban: A15 strain) which recognize viral structural proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Dengue and dengue haemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Dengue: defining protective versus pathologic immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Virus-Induced Decline in Soluble Vascular Endothelial Growth Receptor 2 Is Associated with Plasma Leakage in Dengue Hemorrhagic Fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

Prospects for a dengue virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.025

10.1016/J.VIROL.2009.03.025

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference